open access

Vol 13, No 2 (2009)
Prace oryginalne
Published online: 2009-03-10
Get Citation

Hypertension in patients treated with renal replacement therapy

Grażyna Kobus, Jolanta Małyszko, Michał Myśliwiec, Hanna Bachórzewska-Gajewska
Nadciśnienie tętnicze 2009;13(2):114-119.

open access

Vol 13, No 2 (2009)
Prace oryginalne
Published online: 2009-03-10

Abstract


Background Hypertension is an important risk factor for morbidity and mortality in patients with chronic kidney diseases. The aim of the study was to assess prevalence of hypertension in patients on renal replacement therapy
Material and methods The studies were performed on 174 dialyzed patients and 101 kidney allograft recipients.
Results Hypertension was most prevalent in kidney allograft recipients (84.7%). In the population of dialyzed patients, 2.3 of peritoneally dialyzed patients were hypertensive, whereas 50% of hemodialyzed patients were hypertensive. Blood pressure values were significantly higher in kidney allograft recipients when compared to dialyzed patients. In peritoneally dialyzed patients most commonly used hypotensive drugs were b-blockers (77%). In dialyzed patients ACE inhibitors were used significantly more often than in kidney allograft recipients. In patients after kidney transplantation the most commonly used hypotensive drugs were calcium channel blockers. In hemodialyzed patients coronary artery disease was more common in hypertensive patients in contrast to peritoneally dialyzed patients. In kidney allograft recipients coronary artery disease was similarly prevalent in hypertensive and normotensive patients.
Conclusions Hypertension is very common in patients on renal replacement therapy and is affected by the type of the therapy (dialysis vs renal transplantation). Moreover, hypertension is not adequately controlled and renoprotective drugs i.e. ACE inhibitors are underutilized in patients on renal replacement therapy. Coronary artery disease in hypertensive patients on renal replacement therapy is an important risk factor for cardiovascular complication in this vulnerable population.

Abstract


Background Hypertension is an important risk factor for morbidity and mortality in patients with chronic kidney diseases. The aim of the study was to assess prevalence of hypertension in patients on renal replacement therapy
Material and methods The studies were performed on 174 dialyzed patients and 101 kidney allograft recipients.
Results Hypertension was most prevalent in kidney allograft recipients (84.7%). In the population of dialyzed patients, 2.3 of peritoneally dialyzed patients were hypertensive, whereas 50% of hemodialyzed patients were hypertensive. Blood pressure values were significantly higher in kidney allograft recipients when compared to dialyzed patients. In peritoneally dialyzed patients most commonly used hypotensive drugs were b-blockers (77%). In dialyzed patients ACE inhibitors were used significantly more often than in kidney allograft recipients. In patients after kidney transplantation the most commonly used hypotensive drugs were calcium channel blockers. In hemodialyzed patients coronary artery disease was more common in hypertensive patients in contrast to peritoneally dialyzed patients. In kidney allograft recipients coronary artery disease was similarly prevalent in hypertensive and normotensive patients.
Conclusions Hypertension is very common in patients on renal replacement therapy and is affected by the type of the therapy (dialysis vs renal transplantation). Moreover, hypertension is not adequately controlled and renoprotective drugs i.e. ACE inhibitors are underutilized in patients on renal replacement therapy. Coronary artery disease in hypertensive patients on renal replacement therapy is an important risk factor for cardiovascular complication in this vulnerable population.
Get Citation

Keywords

hypertension; kidney transplantation; hemodialysis; peritoneal dialysis

About this article
Title

Hypertension in patients treated with renal replacement therapy

Journal

Arterial Hypertension

Issue

Vol 13, No 2 (2009)

Pages

114-119

Published online

2009-03-10

Bibliographic record

Nadciśnienie tętnicze 2009;13(2):114-119.

Keywords

hypertension
kidney transplantation
hemodialysis
peritoneal dialysis

Authors

Grażyna Kobus
Jolanta Małyszko
Michał Myśliwiec
Hanna Bachórzewska-Gajewska

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail: viamedica@viamedica.pl